PrecisionLife has been awarded a €2.5m non-dilutive grant by the European Innovation Council (EIC) for its TRANSCEND project, to more rapidly and accurately triage and treat patients with endometriosis. The project is based on PrecisionLife’s unique insights into the biological mechanisms underpinning this complex chronic disease. It will develop and clinically validate a rapid and non-invasive precision medicine test to evaluate a patient’s risk of endometriosis and the mechanisms underpinning their disease. It will also enable testing of repurposing drug candidates already identified by…
AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes, and neurons. Supplied fully differentiated and available in high-purity formats, these ready-to-use cells help accelerate research by streamlining lab workflows, eliminating the need for in-house differentiation and minimizing preparation time.
Provided as functionally validated cells, researchers do not need to spend time on in-house validation and can instead apply them directly to their assays without additional steps. This is a major advantage for Contract…
This Aon’s Life Sciences webinar offered an insightful discussion on managing risk in Clinical Trials, focusing on insurance, regulatory requirements, and creating operational efficiencies. Attendees learned about the latest trends in risk transfer, hybrid programs, and how technology is streamlining processes to support clinical trial success.
The Webinar also covered areas including:
Primary Stakeholders and exposures, including contractual and service agreements.
EU directive and CTIS database, the transparency rules, and the impact on insurance
Process Flow and Outsourcing
Global co-…
Appointment of leading financial executive supports continued commercial development
Current CFO at Telesis Bio, former CFO of BioLegend Inc.
Cambridge, UK, 18 February 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the appointment of William J. Kullback to its Board of Directors as a Non-Executive Director (NED).
Bill is a seasoned executive bringing extensive financial experience from large life science tool manufacturers to Nuclera’s leadership team. He joins the board at a crucial…
After a period of significant volatility, a more optimistic outlook is on the horizon for the life sciences industry in 2025. With the right level of preparedness, firms can take full advantage of the potential opportunities the new year will bring.
Key Takeaways
Rapid digital advancements, increasing investor confidence and revolutionary product development all strengthen the environment in which the life sciences industry is operating following recent economic volatility.
Capturing human capital opportunities depends on strategically analyzing talent, workforce skills and total rewards.…
We are pleased to announce the shortlist for the One Nucleus Awards 2025.The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision and enabling support across the stakeholders.Best Professional Services Company:⭐Ip21 Ltd⭐RSSL⭐SRGNon-Profit Research Organisation:⭐Medicines Discovery Catapult⭐The Institute of Cancer Research⭐Wellcome Sanger InstituteR&D Services Provider:⭐O2h discovery⭐Qkine⭐RxCelerateR&D Facility Provider:⭐Babraham Research Campus⭐Canary Wharf Group⭐Stevenage Bioscience CatalystR&D Platform Development Company…
Norwich Research Park has won a prestigious industry award at the inaugural Commute Zero Hero Awards, hosted by climate tech provider Mobilityways. The awards honour organisations and individuals driving innovative commuting solutions that reduce carbon emissions and foster a culture of sustainability.
Norwich Research Park has won the Most Innovative Commuting Solution Award which recognises organisations that develop creative, forward-thinking solutions to transform the commuting experience.
Norwich Research Park won the award for its creative and data-driven approach to fostering a…
Sandwich, Kent, UK / 13 February 2025 / Eleven early-stage companies working in oncology have started ‘Discovery Spark’, a free seven week development programme hosted by leading science and innovation campus Discovery Park, in Sandwich, Kent.
Designed to offer start-ups the skills and tools to lay healthy foundations in their business, refine their commercial strategy and achieve investor readiness, all 11 businesses will be put through their paces to enable future success and growth.
Supported by Capital Enterprise Network, Cancer Tech Accelerator, NHS Kent and Medway Cancer…
Intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025
London, UK, 13 February 2025: European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit development works of a 90,255 sq ft former GSK laboratory at its 28-acre life science campus, Riverlabs, is now underway. This transformation will deliver an adaptable and highly specified sustainable R&D facility, at the most affordable cost to occupiers in the Golden Triangle.
The state-of-the-art…
On 30 January, a high-level delegation from the Department for Science, Innovation and Technology (DSIT) visited Norwich Research Park, to see the cutting edge research and innovation in Engineering Biology that is being conducted on campus.
The team, led by Dr. Isabel Webb, Deputy Director for Technology Strategy and Security, visited Norwich Research Park’s BBSRC (Biotechnology and Biological Sciences Research Council) research institutes - the Quadram Institute, Earlham Institute and John Innes Centre.Hosted by Roz Bird, CEO of Anglia Innovation Partnership, the campus management company…